|
Haematology in BRICS Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017
|
|||||||||||
| Preis** (Lieferformat): |
Versandkostenfrei ** WICHTIG: Alle Preise sind netto ausgewiesen. Abhängig von Versand- und Leistungsort ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Der korrekte Gesamtendpreis wird Ihnen mit der Angabe Ihrer Rechnungsadresse, USt-ID-Nr. etc. im Bestellverlauf ausgewiesen. Weitere Informationen zu den Bestandteilen des Kaufpreises finden Sie in unseren FAQs. |
Zahlen und Fakten zur Studie: | 210 seiten | |||||||||
| Inhalt der Studie: |
Introduction
GlobalData’s new report, “Haematology in BRICS Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017” provides key market data on the Haematology market in the BRI.....
Introduction GlobalData’s new report, “Haematology in BRICS Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017” provides key market data on the Haematology market in the BRICS countries. The report provides value ($m) data for each segment and sub-segment within six market categories – Haematology Reagents, Haemostasis, Immunohaematology, Haematology Rapid Tests, Haematology Analyzers and Haematology Cell Counters. The report also provides company shares and distribution shares data for the overall Haematology market in each of the aforementioned countries. The report is also supplemented with global corporate-level profiles of the key market participants with information on key developments, wherever available. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts. The emerging economies, comprising China, India, Brazil, Russia and South Africa, with a significantly large pool of under-served patients, represent the next big opportunity for the leading medical equipment and devices manufacturers. China remains the world’s most populous country and is consequently home to a large patient base. The country is home to more than 120 million people who are aged 65 or older—a population in continuous need of medical care. India, the second most populous country globally, is home to 1.2 billion people, approximately 5% of which are aged 65 or older. It’s estimated that shortly after 2020, India’s population will surpass China, making it the most populous country in the world. As the population continues to grow and people continue to age, the underlying demand for healthcare is also expected to increase. Scope - Market size data for Haematology market categories – Haematology Reagents, Haemostasis, Immunohaematology, Haematology Rapid Tests, Haematology Analyzers and Haematology Cell Counters. - Annualized market revenues ($m) data for each of the segments and sub-segments within the six market categories. Data from 2003 to 2010, forecast forward for seven years to 2017. - 2010 company shares and distribution shares data for the overall Haematology market in each of the aforementioned countries. - Global corporate-level profiles of key companies operating within the Haematology market in BRICS. - Key players covered include Sysmex Corporation, Siemens Healthcare, Mindray Medical International Limited, Beckman Coulter, Inc., F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., HORIBA, Ltd., Abbott Laboratories, Transasia Bio-Medicals Ltd., Grifols, S.A., Shanghai Kehua Bio-engineering Co., Ltd., DIAGNOSTICA STAGO, Inc. and Nihon Kohden Corporation. Highlights Reasons to buy - Develop business strategies by identifying the key market categories and segments poised for strong growth. - Develop market-entry and market expansion strategies. - Design competition strategies by identifying who-stands-where in the Haematology competitive landscape in BRICS. - Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future. - What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize. Report Highlights Sysmex Corporation Siemens Healthcare Mindray Medical International Limited Beckman Coulter, Inc. F. Hoffmann-La Roche Ltd. Bio-Rad Laboratories, Inc. HORIBA, Ltd. Abbott Laboratories Transasia Bio-Medicals Ltd. Grifols, S.A. Shanghai Kehua Bio-engineering Co., Ltd. DIAGNOSTICA STAGO, Inc. Nihon Kohden Corporation Span Diagnostics Ltd. bioMerieux S.A. J.Mitra & Co. Pvt Ltd Trivitron Healthcare Pvt Ltd. Immucor, Inc. [Studien Infos ausblenden] |
|||||||||||
|
1 Table of Contents 1 Table of Contents 2 1.1 List of Tables 8 1.2 List of Figures 11 2 Introduction 14 2.1 What is This Report About? 14 3 Haematology in BRICS 15 3.1 Haematology, BRICS, Overall Revenue ($m), USD Actual 2003-2017 15 3.2 Haematology, BRICS, Company Share (2009-2010) 21 4 Haematology In Brazil 23 4.1 Haematology, Brazil, Overall Revenue ($m), USD Actual, 2003-2017 23 4.2 Haematology Reagents In Brazil 29 4.2.1 Haematology Reagents, Brazil, Overall Revenue (2003-2017) 29 4.3 Immunohaematology In Brazil 33 4.3.1 Immunohaematology, Brazil, Overall Revenue (2003-2017) 33 4.4 Haematology Cell Counters In Brazil 37 4.4.1 Haematology Cell Counters, Brazil, Overall Revenue (2003-2017) 37 4.5 Haemostasis In Brazil 41 4.5.1 Haemostasis, Brazil, Overall Revenue (2003-2017) 41 4.6 Haematology Rapid Tests In Brazil 45 4.6.1 Haematology Rapid Tests, Brazil, Overall Revenue (2003-2017) 45 4.7 Haematology Analyzers In Brazil 49 4.7.1 Haematology Analyzers, Brazil, Overall Revenue (2003-2017) 49 4.8 Haematology, Brazil, Distribution Share (2009-2010) 51 4.9 Haematology, Brazil, Company Share (2009-2010) 52 5 Haematology In Russian Federation 54 5.1 Haematology, Russian Federation, Overall Revenue ($m), USD Actual, 2003-2017 54 5.2 Haemostasis In Russian Federation 60 5.2.1 Haemostasis, Russian Federation, Overall Revenue (2003-2017) 60 5.3 Immunohaematology In Russian Federation 64 5.3.1 Immunohaematology, Russian Federation, Overall Revenue (2003-2017) 64 5.4 Haematology Reagents In Russian Federation 68 5.4.1 Haematology Reagents, Russian Federation, Overall Revenue (2003-2017) 68 5.5 Haematology Analyzers In Russian Federation 72 5.5.1 Haematology Analyzers, Russian Federation, Overall Revenue (2003-2017) 72 5.6 Haematology Rapid Tests In Russian Federation 74 5.6.1 Haematology Rapid Tests, Russian Federation, Overall Revenue (2003-2017) 74 5.7 Haematology Cell Counters In Russian Federation 78 5.7.1 Haematology Cell Counters, Russian Federation, Overall Revenue (2003-2017) 78 5.8 Haematology, Russian Federation, Distribution Share (2009-2010) 82 5.9 Haematology, Russian Federation, Company Share (2009-2010) 83 6 Haematology In India 85 6.1 Haematology, India, Overall Revenue ($m), USD Actual, 2003-2017 85 6.2 Haematology Reagents In India 91 6.2.1 Haematology Reagents, India, Overall Revenue (2003-2017) 91 6.3 Haematology Analyzers In India 95 6.3.1 Haematology Analyzers, India, Overall Revenue (2003-2017) 95 6.4 Immunohaematology In India 97 6.4.1 Immunohaematology, India, Overall Revenue (2003-2017) 97 6.5 Haemostasis In India 101 6.5.1 Haemostasis, India, Overall Revenue (2003-2017) 101 6.6 Haematology Rapid Tests In India 105 6.6.1 Haematology Rapid Tests, India, Overall Revenue (2003-2017) 105 6.7 Haematology Cell Counters In India 109 6.7.1 Haematology Cell Counters, India, Overall Revenue (2003-2017) 109 6.8 Haematology, India, Distribution Share (2009-2010) 113 6.9 Haematology, India, Company Share (2009-2010) 114 7 Haematology In China 116 7.1 Haematology, China, Overall Revenue ($m), USD Actual, 2003-2017 116 7.2 Haemostasis In China 122 7.2.1 Haemostasis, China, Overall Revenue (2003-2017) 122 7.3 Haematology Reagents In China 126 7.3.1 Haematology Reagents, China, Overall Revenue (2003-2017) 126 7.4 Haematology Rapid Tests In China 130 7.4.1 Haematology Rapid Tests, China, Overall Revenue (2003-2017) 130 7.5 Immunohaematology In China 134 7.5.1 Immunohaematology, China, Overall Revenue (2003-2017) 134 7.6 Haematology Analyzers In China 138 7.6.1 Haematology Analyzers, China, Overall Revenue (2003-2017) 138 7.7 Haematology Cell Counters In China 140 7.7.1 Haematology Cell Counters, China, Overall Revenue (2003-2017) 140 7.8 Haematology, China, Distribution Share (2009-2010) 144 7.9 Haematology, China, Company Share (2009-2010) 145 8 Haematology In South Africa 147 8.1 Haematology, South Africa, Overall Revenue ($m), USD Actual, 2003-2017 147 8.2 Haemostasis In South Africa 153 8.2.1 Haemostasis, South Africa, Overall Revenue (2003-2017) 153 8.3 Haematology Reagents In South Africa 157 8.3.1 Haematology Reagents, South Africa, Overall Revenue (2003-2017) 157 8.4 Immunohaematology In South Africa 161 8.4.1 Immunohaematology, South Africa, Overall Revenue (2003-2017) 161 8.5 Haematology Rapid Tests In South Africa 165 8.5.1 Haematology Rapid Tests, South Africa, Overall Revenue (2003-2017) 165 8.6 Haematology Analyzers In South Africa 169 8.6.1 Haematology Analyzers, South Africa, Overall Revenue (2003-2017) 169 8.7 Haematology Cell Counters In South Africa 171 8.7.1 Haematology Cell Counters, South Africa, Overall Revenue (2003-2017) 171 8.8 Haematology, South Africa, Distribution Share (2009-2010) 175 8.9 Haematology, South Africa, Company Share (2009-2010) 176 9 Overview of Key Companies in BRICS Haematology Market 178 9.1 Sysmex Corporation 178 9.1.1 Company Overview 178 9.1.2 Share in the BRICS Haematology Market 179 9.2 Siemens Healthcare 180 9.2.1 Company Overview 180 9.2.2 Share in the BRICS Haematology Market 181 9.3 Mindray Medical International Limited 182 9.3.1 Company Overview 182 9.3.2 Share in the BRICS Haematology Market 183 9.4 Beckman Coulter, Inc. 184 9.4.1 Company Overview 184 9.4.2 Share in the BRICS Haematology Market 185 9.5 F. Hoffmann-La Roche Ltd. 186 9.5.1 Company Overview 186 9.5.2 Share in the BRICS Haematology Market 187 9.6 Bio-Rad Laboratories, Inc. 188 9.6.1 Company Overview 188 9.6.2 Share in the BRICS Haematology Market 189 9.7 HORIBA, Ltd. 190 9.7.1 Company Overview 190 9.7.2 Share in the BRICS Haematology Market 191 9.8 Abbott Laboratories 192 9.8.1 Company Overview 192 9.8.2 Share in the BRICS Haematology Market 193 9.9 Transasia Bio-Medicals Ltd. 194 9.9.1 Company Overview 194 9.9.2 Share in the BRICS Haematology Market 194 9.10 Grifols, S.A. 195 9.10.1 Company Overview 195 9.10.2 Share in the BRICS Haematology Market 196 9.11 Shanghai Kehua Bio-engineering Co., Ltd. 197 9.11.1 Company Overview 197 9.11.2 Share in the BRICS Haematology Market 197 9.12 DIAGNOSTICA STAGO, Inc. 198 9.12.1 Company Overview 198 9.12.2 Share in the BRICS Haematology Market 199 9.13 Nihon Kohden Corporation 200 9.13.1 Company Overview 200 9.13.2 Share in the BRICS Haematology Market 200 9.14 Span Diagnostics Ltd. 201 9.14.1 Company Overview 201 9.15 bioMerieux S.A. 201 9.15.1 Company Overview 201 9.16 J.Mitra & Co. Pvt Ltd 201 9.16.1 Company Overview 201 9.17 Trivitron Healthcare Pvt Ltd. 202 9.17.1 Company Overview 202 9.18 Immucor, Inc. 202 9.18.1 Company Overview 202 10 Appendix 203 10.1 Definitions of Markets Covered in the Report 204 10.1.1 Haematology 204 10.2 Research Methodology 207 10.3 Secondary Research 207 10.4 Primary Research 208 10.5 Models 208 10.6 Forecasts 209 10.7 Expert Panels 209 10.8 GlobalData Consulting 209 10.9 Currency Conversion 210 10.10 Contact Us 210 10.11 Disclaimer 210 [Inhaltsverzeichnis ausblenden] |
||||||||||||
|
1.1 List of Tables Table 1: Haematology, BRICS, Overall Revenue ($m), USD Actual 2003-2017 16 Table 2: Haematology, BRICS, Overall Revenue ($m), USD Actual Historic, 2003-2010 18 Table 3: Haematology, BRICS, Overall Revenue ($m), USD Actual Forecast, 2010-2017 20 Table 4: Haematology, BRICS, Company Share by Revenue ($m), USD Actual, 2009-2010 22 Table 5: Haematology, Brazil, Overall Revenue ($m), USD Actual, 2003-2017 24 Table 6: Haematology, Brazil, Overall Revenue ($m), USD Actual, Historic, 2003-2010 26 Table 7: Haematology, Brazil, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 28 Table 8: Haematology Reagents, Brazil, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 30 Table 9: Table 10: Haematology Reagents, Brazil, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 32 Table 11: Immunohaematology, Brazil, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 34 Table 12: Table 13: Immunohaematology, Brazil, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 36 Table 14: Haematology Cell Counters, Brazil, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 38 Table 15: Table 16: Haematology Cell Counters, Brazil, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 40 Table 17: Haemostasis, Brazil, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 42 Table 18: Table 19: Haemostasis, Brazil, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 44 Table 20: Haematology Rapid Tests, Brazil, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 46 Table 21: Table 22: Haematology Rapid Tests, Brazil, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 48 Table 23: Haematology Analyzers, Brazil, Revenue ($m), USD Actual, Historic, 2003-2010 49 Table 24: Table 25: Haematology Analyzers, Brazil, Revenue ($m), USD Actual, Forecast, 2010-2017 50 Table 26: Haematology, Brazil, Distribution Share by Revenue ($m), USD Actual, 2009-2010 51 Table 27: Haematology, Brazil, Company Share by Revenue ($m), USD Actual, 2009-2010 53 Table 28: Haematology, Russian Federation, Overall Revenue ($m), USD Actual, 2003-2017 55 Table 29: Haematology, Russian Federation, Overall Revenue ($m), USD Actual, Historic, 2003-2010 57 Table 30: Haematology, Russian Federation, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 59 Table 31: Haemostasis, Russian Federation, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 61 Table 32: Table 33: Haemostasis, Russian Federation, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 63 Table 34: Immunohaematology, Russian Federation, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 65 Table 35: Table 36: Immunohaematology, Russian Federation, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 67 Table 37: Haematology Reagents, Russian Federation, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 69 Table 38: Haematology Reagents, Russian Federation, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 71 Table 39: Haematology Analyzers, Russian Federation, Revenue ($m), USD Actual, Historic, 2003-2010 72 Table 40: Haematology Analyzers, Russian Federation, Revenue ($m), USD Actual, Forecast, 2010-2017 73 Table 41: Haematology Rapid Tests, Russian Federation, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 75 Table 42: Haematology Rapid Tests, Russian Federation, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 77 Table 43: Haematology Cell Counters, Russian Federation, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 79 Table 44: Haematology Cell Counters, Russian Federation, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 81 Table 45: Haematology, Russian Federation, Distribution Share by Revenue ($m), USD Actual, 2009-2010 82 Table 46: Haematology, Russian Federation, Company Share by Revenue ($m), USD Actual, 2009-2010 84 Table 47: Haematology, India, Overall Revenue ($m), USD Actual, 2003-2017 86 Table 48: Haematology, India, Overall Revenue ($m), USD Actual, Historic, 2003-2010 88 Table 49: Haematology, India, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 90 Table 50: Haematology Reagents, India, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 92 Table 51: Table 52: Haematology Reagents, India, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 94 Table 53: Haematology Analyzers, India, Revenue ($m), USD Actual, Historic, 2003-2010 95 Table 54: Table 55: Haematology Analyzers, India, Revenue ($m), USD Actual, Forecast, 2010-2017 96 Table 56: Immunohaematology, India, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 98 Table 57: Table 58: Immunohaematology, India, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 100 Table 59: Haemostasis, India, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 102 Table 60: Table 61: Haemostasis, India, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 104 Table 62: Haematology Rapid Tests, India, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 106 Table 63: Table 64: Haematology Rapid Tests, India, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 108 Table 65: Haematology Cell Counters, India, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 110 Table 66: Table 67: Haematology Cell Counters, India, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 112 Table 68: Haematology, India, Distribution Share by Revenue ($m), USD Actual, 2009-2010 113 Table 69: Haematology, India, Company Share by Revenue ($m), USD Actual, 2009-2010 115 Table 70: Haematology, China, Overall Revenue ($m), USD Actual, 2003-2017 117 Table 71: Haematology, China, Overall Revenue ($m), USD Actual, Historic, 2003-2010 119 Table 72: Haematology, China, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 121 Table 73: Haemostasis, China, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 123 Table 74: Table 75: Haemostasis, China, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 125 Table 76: Haematology Reagents, China, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 127 Table 77: Table 78: Haematology Reagents, China, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 129 Table 79: Haematology Rapid Tests, China, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 131 Table 80: Table 81: Haematology Rapid Tests, China, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 133 Table 82: Immunohaematology, China, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 135 Table 83: Table 84: Immunohaematology, China, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 137 Table 85: Haematology Analyzers, China, Revenue ($m), USD Actual, Historic, 2003-2010 138 Table 86: Table 87: Haematology Analyzers, China, Revenue ($m), USD Actual, Forecast, 2010-2017 139 Table 88: Haematology Cell Counters, China, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 141 Table 89: Table 90: Haematology Cell Counters, China, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 143 Table 91: Haematology, China, Distribution Share by Revenue ($m), USD Actual, 2009-2010 144 Table 92: Haematology, China, Company Share by Revenue ($m), USD Actual, 2009-2010 146 Table 93: Haematology, South Africa, Overall Revenue ($m), USD Actual, 2003-2017 148 Table 94: Haematology, South Africa, Overall Revenue ($m), USD Actual, Historic, 2003-2010 150 Table 95: Haematology, South Africa, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 152 Table 96: Haemostasis, South Africa, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 154 Table 97: Table 98: Haemostasis, South Africa, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 156 Table 99: Haematology Reagents, South Africa, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 158 Table 100: Table 101: Haematology Reagents, South Africa, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 160 Table 102: Immunohaematology, South Africa, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 162 Table 103: Immunohaematology, South Africa, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 164 Table 104: Haematology Rapid Tests, South Africa, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 166 Table 105: Table 106: Haematology Rapid Tests, South Africa, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 168 Table 107: Haematology Analyzers, South Africa, Revenue ($m), USD Actual, Historic, 2003-2010 169 Table 108: Table 109: Haematology Analyzers, South Africa, Revenue ($m), USD Actual, Forecast, 2010-2017 170 Table 110: Haematology Cell Counters, South Africa, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 172 Table 111: Haematology Cell Counters, South Africa, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 174 Table 112: Haematology, South Africa, Distribution Share by Revenue ($m), USD Actual, 2009-2010 175 Table 113: Haematology, South Africa, Company Share by Revenue ($m), USD Actual, 2009-2010 177 Table 114: Sysmex Corporation, Revenue ($m), USD Actual, BRICS Haematology Market, 2010 179 Table 115: Siemens Healthcare, Revenue ($m), USD Actual, BRICS Haematology Market, 2010 181 Table 116: Mindray Medical International Limited, Revenue ($m), USD Actual, BRICS Haematology Market, 2010 183 Table 117: Beckman Coulter, Inc., Revenue ($m), USD Actual, BRICS Haematology Market, 2010 185 Table 118: F. Hoffmann-La Roche Ltd., Revenue ($m), USD Actual, BRICS Haematology Market, 2010 187 Table 119: Bio-Rad Laboratories, Inc., Revenue ($m), USD Actual, BRICS Haematology Market, 2010 189 Table 120: HORIBA, Ltd., Revenue ($m), USD Actual, BRICS Haematology Market, 2010 191 Table 121: Abbott Laboratories, Revenue ($m), USD Actual, BRICS Haematology Market, 2010 193 Table 122: Transasia Bio-Medicals Ltd., Revenue ($m), USD Actual, BRICS Haematology Market, 2010 194 Table 123: Grifols, S.A., Revenue ($m), USD Actual, BRICS Haematology Market, 2010 196 Table 124: Shanghai Kehua Bio-engineering Co., Ltd., Revenue ($m), USD Actual, BRICS Haematology Market, 2010 197 Table 125: DIAGNOSTICA STAGO, Inc., Revenue ($m), USD Actual, BRICS Haematology Market, 2010 199 Table 126: Nihon Kohden Corporation, Revenue ($m), USD Actual, BRICS Haematology Market, 2010 200 Table 127: USD to Local Currency, BRICS, Average Exchange Rate, 2003-2010 210 1.2 List of Figures Figure 1: Haematology, BRICS, Overall Revenue ($m), USD Actual 2003-2017 15 Figure 2: Haematology, BRICS, Overall Revenue ($m), USD Actual Historic, 2003-2010 17 Figure 3: Haematology, BRICS, Overall Revenue ($m), USD Actual Forecast, 2010-2017 19 Figure 4: Haematology, BRICS, Company Share (%), 2010 21 Figure 5: Haematology, Brazil, Overall Revenue ($m), USD Actual, 2003-2017 23 Figure 6: Haematology, Brazil, Overall Revenue ($m), USD Actual, Historic, 2003-2010 25 Figure 7: Haematology, Brazil, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 27 Figure 8: Haematology Reagents, Brazil, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 29 Figure 9: Haematology Reagents, Brazil, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 31 Figure 10: Immunohaematology, Brazil, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 33 Figure 11: Immunohaematology, Brazil, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 35 Figure 12: Haematology Cell Counters, Brazil, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 37 Figure 13: Haematology Cell Counters, Brazil, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 39 Figure 14: Haemostasis, Brazil, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 41 Figure 15: Haemostasis, Brazil, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 43 Figure 16: Haematology Rapid Tests, Brazil, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 45 Figure 17: Haematology Rapid Tests, Brazil, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 47 Figure 18: Haematology Analyzers, Brazil, Revenue ($m), USD Actual, Historic, 2003-2010 49 Figure 19: Haematology Analyzers, Brazil, Revenue ($m), USD Actual, Forecast, 2010-2017 50 Figure 20: Haematology, Brazil, Company Share (%), 2010 52 Figure 21: Haematology, Russian Federation, Overall Revenue ($m), USD Actual, 2003-2017 54 Figure 22: Haematology, Russian Federation, Overall Revenue ($m), USD Actual, Historic, 2003-2010 56 Figure 23: Haematology, Russian Federation, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 58 Figure 24: Haemostasis, Russian Federation, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 60 Figure 25: Haemostasis, Russian Federation, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 62 Figure 26: Immunohaematology, Russian Federation, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 64 Figure 27: Immunohaematology, Russian Federation, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 66 Figure 28: Haematology Reagents, Russian Federation, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 68 Figure 29: Haematology Reagents, Russian Federation, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 70 Figure 30: Haematology Analyzers, Russian Federation, Revenue ($m), USD Actual, Historic, 2003-2010 72 Figure 31: Haematology Analyzers, Russian Federation, Revenue ($m), USD Actual, Forecast, 2010-2017 73 Figure 32: Haematology Rapid Tests, Russian Federation, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 74 Figure 33: Haematology Rapid Tests, Russian Federation, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 76 Figure 34: Haematology Cell Counters, Russian Federation, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 78 Figure 35: Haematology Cell Counters, Russian Federation, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 80 Figure 36: Haematology, Russian Federation, Company Share (%), 2010 83 Figure 37: Haematology, India, Overall Revenue ($m), USD Actual, 2003-2017 85 Figure 38: Haematology, India, Overall Revenue ($m), USD Actual, Historic, 2003-2010 87 Figure 39: Haematology, India, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 89 Figure 40: Haematology Reagents, India, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 91 Figure 41: Haematology Reagents, India, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 93 Figure 42: Haematology Analyzers, India, Revenue ($m), USD Actual, Historic, 2003-2010 95 Figure 43: Haematology Analyzers, India, Revenue ($m), USD Actual, Forecast, 2010-2017 96 Figure 44: Immunohaematology, India, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 97 Figure 45: Immunohaematology, India, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 99 Figure 46: Haemostasis, India, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 101 Figure 47: Haemostasis, India, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 103 Figure 48: Haematology Rapid Tests, India, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 105 Figure 49: Haematology Rapid Tests, India, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 107 Figure 50: Haematology Cell Counters, India, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 109 Figure 51: Haematology Cell Counters, India, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 111 Figure 52: Haematology, India, Company Share (%), 2010 114 Figure 53: Haematology, China, Overall Revenue ($m), USD Actual, 2003-2017 116 Figure 54: Haematology, China, Overall Revenue ($m), USD Actual, Historic, 2003-2010 118 Figure 55: Haematology, China, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 120 Figure 56: Haemostasis, China, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 122 Figure 57: Haemostasis, China, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 124 Figure 58: Haematology Reagents, China, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 126 Figure 59: Haematology Reagents, China, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 128 Figure 60: Haematology Rapid Tests, China, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 130 Figure 61: Haematology Rapid Tests, China, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 132 Figure 62: Immunohaematology, China, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 134 Figure 63: Immunohaematology, China, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 136 Figure 64: Haematology Analyzers, China, Revenue ($m), USD Actual, Historic, 2003-2010 138 Figure 65: Haematology Analyzers, China, Revenue ($m), USD Actual, Forecast, 2010-2017 139 Figure 66: Haematology Cell Counters, China, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 140 Figure 67: Haematology Cell Counters, China, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 142 Figure 68: Haematology, China, Company Share (%), 2010 145 Figure 69: Haematology, South Africa, Overall Revenue ($m), USD Actual, 2003-2017 147 Figure 70: Haematology, South Africa, Overall Revenue ($m), USD Actual, Historic, 2003-2010 149 Figure 71: Haematology, South Africa, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 151 Figure 72: Haemostasis, South Africa, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 153 Figure 73: Haemostasis, South Africa, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 155 Figure 74: Haematology Reagents, South Africa, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 157 Figure 75: Haematology Reagents, South Africa, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 159 Figure 76: Immunohaematology, South Africa, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 161 Figure 77: Immunohaematology, South Africa, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 163 Figure 78: Haematology Rapid Tests, South Africa, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 165 Figure 79: Haematology Rapid Tests, South Africa, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 167 Figure 80: Haematology Analyzers, South Africa, Revenue ($m), USD Actual, Historic, 2003-2010 169 Figure 81: Haematology Analyzers, South Africa, Revenue ($m), USD Actual, Forecast, 2010-2017 170 Figure 82: Haematology Cell Counters, South Africa, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 171 Figure 83: Haematology Cell Counters, South Africa, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 173 Figure 84: Haematology, South Africa, Company Share (%), 2010 176 Figure 85: Sysmex Corporation, Company Share (%), BRICS Haematology Market, 2010 179 Figure 86: Siemens Healthcare, Company Share (%), BRICS Haematology Market, 2010 181 Figure 87: Mindray Medical International Limited, Company Share (%), BRICS Haematology Market, 2010 183 Figure 88: Beckman Coulter, Inc., Company Share (%), BRICS Haematology Market, 2010 185 Figure 89: F. Hoffmann-La Roche Ltd., Company Share (%), BRICS Haematology Market, 2010 187 Figure 90: Bio-Rad Laboratories, Inc., Company Share (%), BRICS Haematology Market, 2010 189 Figure 91: HORIBA, Ltd., Company Share (%), BRICS Haematology Market, 2010 191 Figure 92: Abbott Laboratories, Company Share (%), BRICS Haematology Market, 2010 193 Figure 93: Grifols, S.A., Company Share (%), BRICS Haematology Market, 2010 196 Figure 94: DIAGNOSTICA STAGO, Inc., Company Share (%), BRICS Haematology Market, 2010 199 [Tabellenverzeichnis ausblenden] |
||||||||||||
| Hinweis: | * Der Rechnungsbetrag für diese Studie wird in $ (Dollar) ausgewiesen. Kunden aus dem Inland bekommen von uns eine Rechnung in Euro, umgerechnet zum letztwöchigen Schlusskurs | |||||||||||
|
|
||||||||||||
